After critics lambasted Gilead for grabbing the FDA’s special rare drug status on remdesivir, they’re giving it back

Two days after Gilead won orphan drug status for remdesivir as a potential treatment for Covid-19, they’re handing it back. The company was slammed from several sides after Gilead reported that the FDA had come through with the special status, which comes with 7 years of market exclusivity, the waiver…

Click to view original post